WebJoining forces with leading hematologists, Janssen’s team of experts and further research organizations, we are excited to generate significant, current and collaborative insights contributing to the development of multiple myeloma treatments." Lenka Kellermann, Founder and Owner, OncologyInformationService & CancerDataNet, Freiburg, Germany WebOct 18, 2024 · Janssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory landscape. In my 26 years of industry experience, I’ve often found the...
Honeur (Heamatology Outcomes Network in Europe): A …
WebMar 30, 2024 · Solutions being explored at Janssen include a more holistic determination of value (to incorporate a broader societal perspective, including cost savings from social services and impact on carers), and an increasing emphasis on novel payment mechanisms. WebSep 29, 2024 · For over three decades, Janssen has dedicated itself to advancing research and solutions to meet the needs of people with haematological malignancies. Our goal is to not only make blood-related conditions treatable, but ultimately preventable and curable. [3] Janssen & Haematology mgh wang surgery facilities
Home - HONEUR
WebHONEUR’s cross-functional team; What data partners are saying; HONEUR materials; How it works . How it works; Core principles; Research questions; Become a data partner . How to become an HONEUR data partner; Our investment in real world data; Join the network; Contact; News ; FAQs WebSince Janssen set it up, HONEUR has been growing in size and scientific impact. We currently have nineteen partners across Europe, from nine countries, with data from … WebApr 11, 2024 · HONEUR is a Janssen-led initiative that aims to create better outcomes for patients by harnessing real world data and the insights it can provide. Through a secure, … mgh wasserburg